| Literature DB >> 33610757 |
Sarwar Beg1, Waleed H Almalki2, Fahmida Khatoon3, Khalid S Alharbi4, Saad Alghamdi5, Md Habban Akhter6, Habibullah Khalilullah7, Abdullah A Baothman8, Abdul Hafeez9, Mahfoozur Rahman10, Sohail Akhter11, Hani Choudhry12.
Abstract
Cancer vaccines consist of nucleic acid derivatives such as plasmid DNA, small interfering RNA and mRNA, and can be customized according to the patient's needs. Nanomedicines have proven to be exceptionally good as miniaturized drug carriers, and thus they offer great advantages for delivering cancer vaccines. This review provides an overview of the literature on cancer vaccines, from their inception to current developments in the field.Entities:
Mesh：
Substances：
Year: 2021 PMID： 33610757 DOI： 10.1016/j.drudis.2021.02.013
Source DB: PubMed Journal: Drug Discov Today ISSN： 1359-6446 Impact factor: 7.851